CA Stock MarketDetailed Quotes

QNTM Quantum BioPharma Ltd

Watchlist
  • 5.900
  • +0.050+0.85%
15min DelayMarket Closed Dec 16 15:59 ET
11.32MMarket Cap-0.33P/E (TTM)

Quantum BioPharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
45.48%4.07M
-36.45%3.47M
-75.77%2.25M
-28.65%19.57M
-69.83%2.01M
-61.40%2.8M
-25.89%5.46M
57.63%9.3M
-18.71%27.43M
8.84%6.66M
Selling and administrative expenses
19.42%3.21M
-11.22%2.44M
-66.32%1.97M
-17.37%13.2M
-31.70%1.92M
-36.67%2.69M
-43.13%2.74M
51.71%5.86M
-31.62%15.98M
-32.51%2.81M
-General and administrative expense
19.42%3.21M
-11.22%2.44M
-66.32%1.97M
-17.37%13.2M
-31.70%1.92M
-36.67%2.69M
-43.13%2.74M
51.71%5.86M
-31.62%15.98M
-32.51%2.81M
Research and development costs
2,358.00%744.8K
-44.24%897.99K
-93.07%160.26K
-44.16%3.86M
-101.11%-29.96K
-101.77%-32.99K
14.05%1.61M
146.69%2.31M
9.21%6.91M
216.16%2.69M
Depreciation amortization depletion
-17.71%120.81K
-87.64%136.81K
-89.37%120.14K
-44.76%2.51M
-89.44%122.22K
-87.19%146.81K
-2.21%1.11M
2.62%1.13M
12.16%4.54M
4.54%1.16M
-Depreciation and amortization
-17.71%120.81K
-87.64%136.81K
-89.37%120.14K
-44.76%2.51M
-89.44%122.22K
-87.19%146.81K
-2.21%1.11M
2.62%1.13M
12.16%4.54M
4.54%1.16M
Operating profit
-45.48%-4.07M
36.45%-3.47M
75.77%-2.25M
28.65%-19.57M
69.83%-2.01M
61.40%-2.8M
25.89%-5.46M
-57.63%-9.3M
18.71%-27.43M
-8.84%-6.66M
Net non-operating interest income (expenses)
-12.01%153.5K
-48.40%96.07K
-41.07%160.11K
146.48%786.06K
-48.72%153.78K
252.80%174.45K
1,426.42%186.16K
1,758.37%271.67K
568.22%318.91K
1,126.82%299.88K
Non-operating interest income
-5.86%163.87K
-43.91%104.42K
-36.65%172.52K
113.84%786.36K
-48.74%153.79K
165.76%174.07K
8,293.28%186.16K
--272.34K
28,362.46%367.74K
--300.02K
Non-operating interest expense
--10.37K
--8.36K
1,761.17%12.41K
-99.39%299
-91.11%12
----
--0
-95.93%667
-29.66%48.82K
-99.54%135
Total other finance cost
----
----
----
----
----
---380
----
----
----
----
Other net income (expenses)
-106.41%-95.71K
110.41%22.33K
100.18%1.68K
35.97%553.46K
-3.47%204.12K
1,870.33%1.49M
63.12%-214.5K
-304.58%-930.28K
422.57%407.04K
1,514.39%211.45K
Gain on sale of security
79.14%-108.03K
-96.80%22.33K
104.25%19.15K
-40.80%170.25K
107.74%440.31K
-1,442.01%-517.98K
220.04%698.1K
-221.02%-450.18K
263.42%287.58K
1,517.77%211.96K
Special income (charges)
--12.32K
--0
96.36%-17.48K
---4.56M
---236.19K
--0
---3.84M
---480.1K
--0
--0
-Less:Impairment of capital assets
----
----
----
--4.56M
----
----
----
----
--0
--0
-Less:Other special charges
---12.32K
----
--17.48K
----
----
----
----
----
----
----
-Less:Write off
--0
--0
--0
----
----
--0
--3.84M
--480.1K
----
----
Other non-operating income (expenses)
----
----
----
4,034.69%4.94M
--0
5,303.91%2.01M
--2.93M
----
139.90%119.45K
---506
Income before tax
-254.96%-4.02M
38.94%-3.35M
79.00%-2.09M
31.73%-18.23M
73.14%-1.65M
84.13%-1.13M
31.07%-5.49M
-82.34%-9.96M
21.32%-26.7M
0.24%-6.15M
Income tax
Earnings from equity interest net of tax
Net income
-254.96%-4.02M
38.94%-3.35M
79.00%-2.09M
22.77%-18.23M
73.14%-1.65M
84.13%-1.13M
-24.10%-5.49M
-68.62%-9.96M
33.10%-23.61M
3.14%-6.15M
Net income continuous operations
-254.96%-4.02M
38.94%-3.35M
79.00%-2.09M
31.73%-18.23M
73.14%-1.65M
84.13%-1.13M
31.07%-5.49M
-82.34%-9.96M
21.32%-26.7M
0.24%-6.15M
Net income discontinuous operations
----
----
----
--0
----
----
----
----
329.83%3.1M
--0
Noncontrolling interests
-163.67%-188.16K
-240.58K
-188.05K
-328.41K
-257.05K
-71.36K
0
0
0
Net income attributable to the company
-261.11%-3.83M
43.32%-3.11M
80.89%-1.9M
24.17%-17.9M
77.32%-1.39M
85.13%-1.06M
-24.10%-5.49M
-68.62%-9.96M
33.10%-23.61M
3.14%-6.15M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-261.11%-3.83M
43.32%-3.11M
80.89%-1.9M
24.17%-17.9M
77.32%-1.39M
85.13%-1.06M
-24.10%-5.49M
-68.62%-9.96M
33.10%-23.61M
3.14%-6.15M
Diluted earnings per share
-137.22%-4.1697
42.86%-5.2
80.77%-3.25
24.59%-29.9
72.63%-2.8469
85.77%-1.7577
-16.67%-9.1
-73.33%-16.9
39.60%-39.65
-23.08%-10.4
Basic earnings per share
-137.22%-4.1697
42.86%-5.2
80.77%-3.25
24.59%-29.9
72.63%-2.8469
85.77%-1.7577
-16.67%-9.1
-73.33%-16.9
39.60%-39.65
-23.08%-10.4
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 45.48%4.07M-36.45%3.47M-75.77%2.25M-28.65%19.57M-69.83%2.01M-61.40%2.8M-25.89%5.46M57.63%9.3M-18.71%27.43M8.84%6.66M
Selling and administrative expenses 19.42%3.21M-11.22%2.44M-66.32%1.97M-17.37%13.2M-31.70%1.92M-36.67%2.69M-43.13%2.74M51.71%5.86M-31.62%15.98M-32.51%2.81M
-General and administrative expense 19.42%3.21M-11.22%2.44M-66.32%1.97M-17.37%13.2M-31.70%1.92M-36.67%2.69M-43.13%2.74M51.71%5.86M-31.62%15.98M-32.51%2.81M
Research and development costs 2,358.00%744.8K-44.24%897.99K-93.07%160.26K-44.16%3.86M-101.11%-29.96K-101.77%-32.99K14.05%1.61M146.69%2.31M9.21%6.91M216.16%2.69M
Depreciation amortization depletion -17.71%120.81K-87.64%136.81K-89.37%120.14K-44.76%2.51M-89.44%122.22K-87.19%146.81K-2.21%1.11M2.62%1.13M12.16%4.54M4.54%1.16M
-Depreciation and amortization -17.71%120.81K-87.64%136.81K-89.37%120.14K-44.76%2.51M-89.44%122.22K-87.19%146.81K-2.21%1.11M2.62%1.13M12.16%4.54M4.54%1.16M
Operating profit -45.48%-4.07M36.45%-3.47M75.77%-2.25M28.65%-19.57M69.83%-2.01M61.40%-2.8M25.89%-5.46M-57.63%-9.3M18.71%-27.43M-8.84%-6.66M
Net non-operating interest income (expenses) -12.01%153.5K-48.40%96.07K-41.07%160.11K146.48%786.06K-48.72%153.78K252.80%174.45K1,426.42%186.16K1,758.37%271.67K568.22%318.91K1,126.82%299.88K
Non-operating interest income -5.86%163.87K-43.91%104.42K-36.65%172.52K113.84%786.36K-48.74%153.79K165.76%174.07K8,293.28%186.16K--272.34K28,362.46%367.74K--300.02K
Non-operating interest expense --10.37K--8.36K1,761.17%12.41K-99.39%299-91.11%12------0-95.93%667-29.66%48.82K-99.54%135
Total other finance cost -----------------------380----------------
Other net income (expenses) -106.41%-95.71K110.41%22.33K100.18%1.68K35.97%553.46K-3.47%204.12K1,870.33%1.49M63.12%-214.5K-304.58%-930.28K422.57%407.04K1,514.39%211.45K
Gain on sale of security 79.14%-108.03K-96.80%22.33K104.25%19.15K-40.80%170.25K107.74%440.31K-1,442.01%-517.98K220.04%698.1K-221.02%-450.18K263.42%287.58K1,517.77%211.96K
Special income (charges) --12.32K--096.36%-17.48K---4.56M---236.19K--0---3.84M---480.1K--0--0
-Less:Impairment of capital assets --------------4.56M------------------0--0
-Less:Other special charges ---12.32K------17.48K----------------------------
-Less:Write off --0--0--0----------0--3.84M--480.1K--------
Other non-operating income (expenses) ------------4,034.69%4.94M--05,303.91%2.01M--2.93M----139.90%119.45K---506
Income before tax -254.96%-4.02M38.94%-3.35M79.00%-2.09M31.73%-18.23M73.14%-1.65M84.13%-1.13M31.07%-5.49M-82.34%-9.96M21.32%-26.7M0.24%-6.15M
Income tax
Earnings from equity interest net of tax
Net income -254.96%-4.02M38.94%-3.35M79.00%-2.09M22.77%-18.23M73.14%-1.65M84.13%-1.13M-24.10%-5.49M-68.62%-9.96M33.10%-23.61M3.14%-6.15M
Net income continuous operations -254.96%-4.02M38.94%-3.35M79.00%-2.09M31.73%-18.23M73.14%-1.65M84.13%-1.13M31.07%-5.49M-82.34%-9.96M21.32%-26.7M0.24%-6.15M
Net income discontinuous operations --------------0----------------329.83%3.1M--0
Noncontrolling interests -163.67%-188.16K-240.58K-188.05K-328.41K-257.05K-71.36K000
Net income attributable to the company -261.11%-3.83M43.32%-3.11M80.89%-1.9M24.17%-17.9M77.32%-1.39M85.13%-1.06M-24.10%-5.49M-68.62%-9.96M33.10%-23.61M3.14%-6.15M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -261.11%-3.83M43.32%-3.11M80.89%-1.9M24.17%-17.9M77.32%-1.39M85.13%-1.06M-24.10%-5.49M-68.62%-9.96M33.10%-23.61M3.14%-6.15M
Diluted earnings per share -137.22%-4.169742.86%-5.280.77%-3.2524.59%-29.972.63%-2.846985.77%-1.7577-16.67%-9.1-73.33%-16.939.60%-39.65-23.08%-10.4
Basic earnings per share -137.22%-4.169742.86%-5.280.77%-3.2524.59%-29.972.63%-2.846985.77%-1.7577-16.67%-9.1-73.33%-16.939.60%-39.65-23.08%-10.4
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data